The DEA lowered the domestic creation quota all the strategy to zero in 1981 when the final American company stopped making it; Congress took the unusual action of passing a special act that moved Quaalude to Schedule I in 1983; and also the DEA undertook an energetic diplomatic work to shut down methaqualone creation in other international locatio